Table 2

Supplementation impact on malaria and general morbidity


Placebo
Supplemented
RR (95% CI)
p-value

Number of fever episodes (mean ± SD)
2.04 ± 1.2
1.63 ± 1.2
-
0.038
Number of malaria episodes (mean ± SD)
1.5 ± 1.005
1 ± 0.93
-
0.029
P*PFever episodes
153
119
1.28 (1.09–2.94)
0.030
P*PMalaria episodes
106
74
1.43 (1.10–2.40)
0.025
Free of pathologies
17% (9–25)
31% (16–46)
-
0.05
Cough episodes
51,3 (40–62.6)
45,9% (34.6–57.2)
-
0.510
Diarrhea episodes
52,7% (41.4–64)
28,3% (18.1–38.5)
-
0.002
Geometric mean density P falciparum (asexual forms/μl)
10672 (7589–15007)
7704 (5409–10971)
-
0.049

P*PNumber of episodes

Mean ± SD or % (CI 95%)

Child-years was 37 in each group

Zeba et al. Nutrition Journal 2008 7:7   doi:10.1186/1475-2891-7-7